$12.54
0.02[0.16%]
At close: May 10
$12.54
0[0.00%]
After Hours: 4:00PM EDT
Zentalis Pharma
(NASDAQ:ZNTL)Zentalis Pharma Stock (NASDAQ:ZNTL), Quotes and News Summary
Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
| Open | $12.490 |
| Close | $12.540 |
| Volume / Avg. | 620.927K / 811.688K |
| Day Range | 11.780 - 12.740 |
| 52 Wk Range | 9.560 - 31.460 |
| Market Cap | $890.506M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 50 |
| Short Interest | 47.34% |
| Days to Cover | 22.95 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zentalis Pharma (ZNTL) stock?
You can purchase shares of Zentalis Pharma (NASDAQ: ZNTL) through any online brokerage.
Who are Zentalis Pharma's (ZNTL) competitors?
Other companies in Zentalis Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB) and Cogent Biosciences (NASDAQ:COGT).
What is the target price for Zentalis Pharma (ZNTL) stock?
The latest price target for Zentalis Pharma (NASDAQ: ZNTL) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 40.00 expecting ZNTL to rise to within 12 months (a possible 218.98% upside). 21 analyst firms have reported ratings in the last year.
Current Stock Price for Zentalis Pharma (ZNTL)?
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $12.54 last updated May 10, 2024 at 4:00 PM EDT.
Does Zentalis Pharma (ZNTL) pay a dividend?
There are no upcoming dividends for Zentalis Pharma.
When is Zentalis Pharma (NASDAQ:ZNTL) reporting earnings?
Zentalis Pharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Zentalis Pharma (ZNTL) going to split?
There is no upcoming split for Zentalis Pharma.
What sector and industry does Zentalis Pharma (ZNTL) operate in?
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.